Delivery Order SPE2DB22D2103-SPE2DB25FR9UL
- Not listed
- The Defense Logistics Agency awarded a $3,561.92 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $6,297.40 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Restasis 0.05% eye emulsion (60-unit package). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,325.87 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (60 single-use vials) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price, non-set-aside delivery order was fulfilled from the contractor's place of business in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,916.15 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (60 units) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of RESTASIS 0.05% Eye Emulsion in 60-count units. This is a competitively awarded, firm fixed-price delivery order valued at $1,862.70 with no set-aside designation, with an ultimate completion date of July 23, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,541.08 for Restasis 0.05% Eye Emulsion (30-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order represents a non-competitive procurement under a larger indefinite delivery contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $3,169.04 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-count units, with a contract ceiling value of $22,836.31. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award selection. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order...
- The Defense Logistics Agency awarded a $1,293.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,373.51 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion, a prescription ophthalmic medication, with an ultimate completion date of August 13, 2025. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside basis. The award was made to AmerisourceBergen's Corporate Office division, with performance occurring at the company's Conshohocken, Pennsylvania headquarters. This delivery order...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9ULDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,550.26 to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (60 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's DLA contract vehicle enables supply of pharmaceutical products and medical commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for RESTASIS, an ophthalmic emulsion treatment, exemplifies the routine medical procurement activities executed under the broader pharmaceutical prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 9/11/25 |